OHSU

Lung Cancer Screening Program Share This OHSU Content

Qualifying Participant
  • Are between 55-74 years of age
  • Have smoked at least 30 pack years (for example, smoking more than 1 pack per day for 30 years or 2 packs per day for 15 years)
  • If a former smoker, has quit within the past 15 years.


OHSU is now offering a lung cancer screening program to qualifying participants.

Lung Cancer screening can potentially detect lung cancer at an earlier stage in high risk patients, improving the chance for cure and survival.

The National Lung Screening trial (NLST) has shown that lung cancer screening with low dose CT scan reduced death from lung cancer by 20%.

Low Dose CT Lung Cancer screening is endorsed by many professional societies, such as the American Cancer Society, American College of Chest Physicians, American Society of Clinical Oncology, National Comprehensive Cancer Network and American College of Radiology. These societies have recommended that lung cancer screening should be conducted at a center with subspecialty trained thoracic radiologists as part of a dedicated multidisciplinary team, to provide CT scan interpretations with the most expertise.

AT OHSU, CT interpretation will be performed only by fellowship trained thoracic radiologists; a radiologist with subspecialty training in lung diseases. Using the newest low dose CT (LDCT) scan technologies, earliest detection is possible with as low as possible radiation exposure.

Positive screening results requiring further interventions will be discussed during the weekly OHSU multidisciplinary lung cancer conference and decisions to proceed with any further actions are made by the conference members jointly and in consultation with your personnel health care providers.

The OHSU multidisciplinary lung cancer conference brings together a team of specialists in chest diseases from radiology, thoracic surgery, pulmonary medicine, medical oncology, radiation oncology, and pathology.  It is with that collaboration, that the most suitable treatment decisions are made and the best outcomes are achieved. Every patient will be discussed individually providing for an individualized and therefore optimized treatment plan.

For more information

Bart Moulton, MD
Pulmonary Medicine
503-494-1620

National Lung Cancer Partnership

Thoracic Radiologists